Abingworth LLP 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-04-08 4:35 pm Purchase |
2022-03-29 | 13D | Soleno Therapeutics, Inc. SLNO |
Abingworth LLP | 1,224,558 15.300% |
521,598 (+74.20%) |
Filing |